51-year old man with tingling, burning and progressive limb weakness
暂无分享,去创建一个
[1] M. Reilly,et al. POEMS neuropathy: optimising diagnosis and management , 2018, Practical Neurology.
[2] S. W. Rizvi,et al. Chronic Inflammatory Demyelinating Polyneuropathy (CIDP): An Uncommon Manifestation of Systemic Lupus Erythematosus (SLE) , 2017, The American journal of case reports.
[3] A. Dispenzieri. POEMS syndrome: 2017 Update on diagnosis, risk stratification, and management , 2017, American journal of hematology.
[4] J. Mandrekar,et al. Clinical spectrum of Castleman disease–associated neuropathy , 2016, Neurology.
[5] E. Jaffe,et al. Multicentric Castleman disease: Where are we now? , 2016, Seminars in diagnostic pathology.
[6] R. Layzer,et al. Sarcoid polyneuropathy masquerading as chronic inflammatory demyelinating polyneuropathy , 2015, Muscle & nerve.
[7] G. Parry,et al. Acquired Immunologic Neuropathies , 2015, Seminars in Neurology.
[8] E. Anagnostou,et al. Chronic inflammatory demyelinating polyneuropathy associated with neurosyphilis. , 2015, The American journal of the medical sciences.
[9] G. Sobue,et al. Clinicopathological features of neuropathy associated with lymphoma. , 2013, Brain : a journal of neurology.
[10] W. Louthrenoo,et al. Sensitivity and specificity of ANA and anti-dsDNA in the diagnosis of systemic lupus erythematosus: a comparison using control sera obtained from healthy individuals and patients with multiple medical problems. , 2013, Asian Pacific journal of allergy and immunology.
[11] R. Lewis,et al. Evaluation of a patient with suspected chronic demyelinating polyneuropathy. , 2013, Handbook of clinical neurology.
[12] D. Weisenburger,et al. The clinical spectrum of Castleman's disease , 2012, American journal of hematology.
[13] J. Mandrekar,et al. Uniform demyelination and more severe axonal loss distinguish POEMS syndrome from CIDP , 2012, Journal of Neurology, Neurosurgery & Psychiatry.
[14] A. Dispenzieri,et al. Bone marrow histopathology in POEMS syndrome: a distinctive combination of plasma cell, lymphoid, and myeloid findings in 87 patients. , 2011, Blood.
[15] C. Sommer,et al. Chronic inflammatory demyelinating polyradiculoneuropathy: diagnostic and therapeutic challenges for a treatable condition , 2010, The Lancet Neurology.
[16] Morel Ayala Zoilo,et al. Chronic inflammatory demyelinating polyradiculoneuropathy in a boy with systemic lupus erythematosus , 2010, Rheumatology International.
[17] H. Watanabe,et al. Neuropathic pain correlates with myelinated fibre loss and cytokine profile in POEMS syndrome , 2008, Journal of Neurology, Neurosurgery, and Psychiatry.
[18] F. Ducray,et al. [Chronic inflammatory demyelinating polyneuropathy and sarcoidosis: fortuitous association?]. , 2007, Revue neurologique.
[19] V. Chong,et al. Chronic inflammatory demyelinating polyneuropathy associated with intestinal tuberculosis. , 2007, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.
[20] M. Weisman,et al. Chronic inflammatory demyelinating polyneuropathy in patients with systemic lupus erythematosus: prognosis and outcome. , 2005, Seminars in arthritis and rheumatism.
[21] D. Karcher,et al. Lymphoma and peripheral neuropathy: A clinical review , 2005, Muscle & nerve.
[22] Y. Kasamon,et al. EBV‐associated lymphoma and chronic inflammatory demyelinating polyneuropathy in an adult without overt immunodeficiency , 2002, American journal of hematology.
[23] A. Verma. Epidemiology and clinical features of HIV‐1 associated neuropathies , 2001, Journal of the peripheral nervous system : JPNS.
[24] A. Avilés,et al. Serum beta 2 microglobulin in solitary plasmocytomata [letter; comment] [see comments] , 1990 .
[25] A. Avilés,et al. Serum beta 2 microglobulin in solitary plasmocytomata. , 1990, Blood.
[26] D. Resnick,et al. Plasma Cell Dyscrasia with Polyneuropathy, Organomegaly, Endocrinopathy, M Protein, and Skin Changes: The POEMS Syndrome REPORT ON TWO CASES AND A REVIEW OF THE LITERATURE , 1980, Medicine.
[27] C. Janeway,et al. The gamma globulins and their clinical significance. III. Hypergammaglobulinemia. , 1959, The New England journal of medicine.
[28] C. Janeway,et al. The gamma globulins and their clinical significance. I. Chemistry, immunology and metabolism. , 1959, The New England journal of medicine.
[29] R. Crow. Peripheral Neuritis in Myelomatosis , 1956, British medical journal.